Hi friends,
Just 21 months ago, Akili Interactive went public with a valuation of over $500 million. But last week, Akili was sold to Virtual Therapeutics for just $34 million.
What the hell went wrong? What can we learn from another large-scale failure in digital therapeutics? And how did a certain billionaire nicknamed ‘The Dictator’ contribute to their demise?
That’s what we get into in this week’s Deep-Dive.
This week in The Hemingway Report;
Akili’s heel: how a deal with The Dictator led to Akili Interactive's demise and what we can learn from the failure
More funding for Aussie psychedelics: Psylo closes an $8m seed round
Tackling Severe Mental Illness (SMI): the company taking a comprehensive, hands-on approach to caring for people with SMI
And all the latest news in mental health innovation
This article is for THR Pro members only
Consider becoming a THR Pro member to access this article as well as more insights, analysis and trends on the mental health industry.
Learn More About THR Pro